The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review - Takeaways - MDSpire

The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review

  • By

  • Luigi Regenburgh De La Motte

  • Francesca Carreras

  • Lorenzo Drago

  • July 6, 2026

  • 0 min

Share

  • 1

    Interindividual variability in response to GLP-1 receptor agonists (GLP-1 RAs) poses challenges in managing obesity and type 2 diabetes.

  • 2

    GLP-1 RAs can remodel gut microbial communities and influence metabolite profiles, impacting metabolic health.

  • 3

    Human studies indicate GLP-1 RA therapy is associated with changes in microbial diversity and specific taxa enrichment.

  • 4

    Baseline microbiota composition may correlate with differential metabolic responses to GLP-1 RA therapy.

  • 5

    Robust longitudinal and interventional studies are needed to explore microbiome-informed stratification in clinical practice.

Original Source(s)

The gut microbiota as a potential determinant of response to GLP-1 receptor agonists: a narrative review

  • by Luigi Regenburgh De La Motte, Francesca Carreras, Lorenzo Drago

  • July 6, 2026

Related Content

Reduced platelet count in mice protects against glucose intolerance and beta cell loss during a long-term high-fat diet

Do Revisions in Rotator Cuff Repair Decline With GLP-1 Use?

Preoperative use was associated with fewer revisions and no increase in short-term complications among patients with obesity, although benefits appeared concentrated in select subgroups.

Editorial: The role of normal blood lipid levels in metabolic and endocrine diseases